Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q4 2024
Institutional positions in Cidara Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +13 vs. Q3 2024
- Shares held
- 6.87M
- +3.57M (+107.8%) vs. Q3 2024
- Total value
- $183.6M
- +$148.1M (+416.3%) vs. Q3 2024
- New holders
- 17
- 14 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 1,092,796 | $29.4M | 0.39% | +389,716+55.4% | Added |
| BVF Inc | 1,092,796 | $29.4M | 1.00% | +389,731+55.4% | Added |
| TCG Crossover Management, LLC | 1,005,901 | $26.1M | 2.55% | +1,005,901 | New |
| VR Adviser, LLC | 765,723 | $20.6M | 1.41% | +765,723 | New |
| Bain Capital Life Sciences Investors, LLC | 703,080 | $18.9M | 2.22% | 00.0% | Unchanged |
| Vivo Capital, LLC | 670,600 | $18.0M | 2.02% | +670,600 | New |
| Adage Capital Partners GP, L.L.C. | 369,954 | $9.94M | 0.02% | +327,199+765.3% | Added |
| Vanguard Group Inc | 217,504 | $5.85M | 0.00% | +36,969+20.5% | Added |
| Checkpoint Capital L.P. | 196,949 | $5.11M | 2.60% | +14,523+8.0% | Added |
| Renaissance Technologies LLC | 95,617 | $2.57M | 0.00% | −2,200−2.2% | Reduced |
| 5AM Venture Management, LLC | 56,725 | $1.52M | 0.36% | 00.0% | Unchanged |
| BlackRock, Inc. | 55,525 | $1.49M | 0.00% | +6,605+13.5% | Added |
| Acuta Capital Partners, LLC | 54,473 | $1.46M | 1.47% | +54,473 | New |
| Ikarian Capital, LLC | 53,940 | $1.45M | 0.41% | +53,940 | New |
| Geode Capital Management, LLC | 53,068 | $1.43M | 0.00% | +170+0.3% | Added |
| Schonfeld Strategic Advisors LLC | 49,557 | $1.33M | 0.01% | +30,057+154.1% | Added |
| StemPoint Capital LP | 47,642 | $1.28M | 0.32% | +47,642 | New |
| UBS Group AG | 46,871 | $1.26M | 0.00% | +40,994+697.5% | Added |
| Susquehanna International Group, LLP | 42,623 | $1.15M | 0.00% | +42,623 | New |
| Millennium Management LLC | 35,960 | $966.6K | 0.00% | +22,041+158.4% | Added |
| Northern Trust Corp | 33,957 | $912.8K | 0.00% | +2,170+6.8% | Added |
| ADAR1 Capital Management, LLC | 24,938 | $670.3K | 0.14% | +24,938 | New |
| State Street Corp | 19,076 | $512.8K | 0.00% | +5,500+40.5% | Added |
| Boothbay Fund Management, LLC | 15,601 | $419.4K | 0.01% | +15,601 | New |
| Alethea Capital Management, LLC | 14,311 | $384.7K | 0.33% | −65,597−82.1% | Reduced |
| Goldman Sachs Group Inc | 13,870 | $372.8K | 0.00% | +13,870 | New |
| Jane Street Group, LLC | 12,714 | $341.8K | 0.00% | +12,714 | New |
| Omers Administration Corp | 12,600 | $338.7K | 0.00% | +12,600 | New |
| Citigroup Inc | 7,584 | $203.9K | 0.00% | +7,584 | New |
| Point72 Asset Management, L.P. | 6,148 | $165.2K | 0.00% | +6,148 | New |
| Morgan Stanley | 2,430 | $65.3K | 0.00% | +2,261+1,337.9% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 2,085 | $56.0K | 0.01% | +2,085 | New |
| Manchester Capital Management LLC | 470 | $12.6K | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 250 | $6.00K | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 198 | $5.33K | 0.00% | +198 | New |
| Bank of America Corp | 50 | $1.34K | 0.00% | +11+28.2% | Added |
| Allworth Financial LP | 40 | $880 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 20 | $538 | 0.00% | +20 | New |
| BNP Paribas Arbitrage, SA | 17 | $457 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 6 | $161 | 0.00% | −100−94.3% | Reduced |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −369,099−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,115−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −855−100.0% | Sold out |
| Pacifica Partners Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |